Correlation Between InfoBank and HLB Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both InfoBank and HLB Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InfoBank and HLB Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InfoBank and HLB Pharmaceutical Co, you can compare the effects of market volatilities on InfoBank and HLB Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InfoBank with a short position of HLB Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of InfoBank and HLB Pharmaceutical.

Diversification Opportunities for InfoBank and HLB Pharmaceutical

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between InfoBank and HLB is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding InfoBank and HLB Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLB Pharmaceutical and InfoBank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InfoBank are associated (or correlated) with HLB Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLB Pharmaceutical has no effect on the direction of InfoBank i.e., InfoBank and HLB Pharmaceutical go up and down completely randomly.

Pair Corralation between InfoBank and HLB Pharmaceutical

Assuming the 90 days trading horizon InfoBank is expected to under-perform the HLB Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, InfoBank is 1.65 times less risky than HLB Pharmaceutical. The stock trades about -0.03 of its potential returns per unit of risk. The HLB Pharmaceutical Co is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,263,000  in HLB Pharmaceutical Co on September 12, 2024 and sell it today you would earn a total of  842,000  from holding HLB Pharmaceutical Co or generate 66.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

InfoBank  vs.  HLB Pharmaceutical Co

 Performance 
       Timeline  
InfoBank 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days InfoBank has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, InfoBank is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
HLB Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HLB Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

InfoBank and HLB Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with InfoBank and HLB Pharmaceutical

The main advantage of trading using opposite InfoBank and HLB Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InfoBank position performs unexpectedly, HLB Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLB Pharmaceutical will offset losses from the drop in HLB Pharmaceutical's long position.
The idea behind InfoBank and HLB Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum